Mast cells in invasive ductal breast cancer: Different behavior in high and minimum hormone-receptive cancers

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2465-2471

  Della Rovere, Filippo ^a   Granata, Angelo ^a   Familiari, Dario ^a   D'Arrigo, Graziella ^a   Mondello, Baldassare ^a   Basile, Giacomo ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Ductal breast cancer; Estrogen receptor; Favorable diagnosis; Mast cell; Progesterone receptor; Tumor cell cytolysis

Indexed keywords

ALCIAN BLUE; ESTROGEN; KI 67 ANTIGEN; PROGESTERONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; ESTHETIC SURGERY; GIEMSA STAIN; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; KI-67 ANTIGEN; MAST CELLS; NEOPLASMS, HORMONE-DEPENDENT; RECEPTOR, ERBB-2;

EID: 34547728242     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ehrlich P: Contributions to the theory and practice of histological staining (Inaugural dissertation, University of Leipzig, 1878) In: Collected Papers of Paul Ehrlich, vol. 1. F. Himmelweit (ed.). London, Pergamon Press, pp. 65-98, 1956.
2. Fisher ER, Sass R, Watkins G, Johal J and Fisher B: Tissue mast cells in breast cancer. Breast Cancer Res Treat 5: 285-291, 1985.
3. Bowers HM Jr, Mahapatro RC and Kennedy JW: Numbers of mast cells in the axillary lymph nodes of breast cancer patients. Cancer 43: 568-573, 1979.
4. Hartveit F, Thoresen S, Tangen M and Maartmann-Moe H: Mast cell changes and tumour dissemination in human breast carcinoma. Invasion Metastasis 4: 146-155, 1984.
5. Aaltomaa S, Lipponen P, Papinaho S and Kosma VM: Mast cells in breast cancer. Anticancer Res 13: 785-788, 1993.
6. Dabiri S, Huntsman D, Makretsov N et al: The presence of stromal mast cells identifies a subset of invasive breast cancers with a favourable prognosis. Mod Pathol 17: 690-695, 2004.
7. Quan C, Wang HL and Lu SJ: Resistance to mammary carcinogenesis in Copenhagen rats: potential roles of vascular endothelial growth factor and mast cells. Cancer Letters 186: 165-175, 2002.
8. Tanooka H, Kitamura Y, Sado T, Tanaka K, Nagase M and Kondo S: Evdence for involvement of mast cells in tumor suppression in mice. J Natl Cancer Inst 69: 1305-1309, 1982.
9. Burtin C, Ponvert C, Fray A, Scheinmann P, Lespinats G, Loridon B, Canu P and Paupe J: Inverse correlation between tumor incidence and tissue histamine levels in W/WV, WV/+, and +/+ mice. J Natl Cancer Inst 74: 671-674, 1985.
10. Hiromatsu Y and Toda S: Mast cells and angiogenesis. Microsc Res Tech 60: 64-69, 2003.
11. Norrby K: Mast cells and angiogenesis. APMIS 110: 355-371, 2002.
12. Ribatti D, Crivellato E, Candussio L, Nico B, Vacca A, Roncali L and Dammacco F: Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane Clin Exp Allergy 31: 602-608, 2001.
13. Benitez-Bribiesca L, Wong A, Utrera D and Castellanos E: The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 49: 1061-1062, 2001.
14. Imada A, Shijubo N, Kojima H and Abe S: Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 15: 1087-1093, 2000.
15. Tamata M, Matsuzaki Y, Onitsuka T: Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg 69: 1686-1690, 2000.
16. Tamata M, Matsuzaki Y and Onitsuka T: Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer 26: 103-108, 1999.
17. della Rovere F, Broccio G, Granata A and Fimiani V: In vivo experimental demonstration that hyperhistaminism counteracts tumor growth. One Rep 1: 175-177, 1994.
18. Ponvert C, Galoppin L and Canu P: Modifications in tissue histamine levels in mast cell-deficient mice (W/Wv) and in their littermates (Wv/+, W/+ and +/+) grafted with a methyl-cholanthrene-induced fibrosarcoma: correlation with tumour rejection. Cancer Lett 85: 125-131, 1994.
19. Simpson JF, Dutt PhL and Page DL: Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 23: 608-611, 1992.
20. Siegel S and Castellan NJ: Statistica Non Parametrica. Milano, Italia, McGraw-Hill, pp. 288-387, 1992.
21. Pesarin F: Multivariate Permutation Tests: with Application in Biostatistics. Chichester, England, John Wiley & Sons, Ltd, 2001.
22. Härdle W and Simar L: Applied Multivariate Statistical Analysis. Berlin, Germany, Springer - Verlag, pp. 323-340, 2003.
23. Ribatti D, Vacca A, Ria R, Marzullo A, Nico B, Filotico R, Roncali L and Dammacco F: Neovascularisation expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneusly with pathological progression in human malignant melanoma. Eur J Cancer 39: 666-674, 2003.
24. Roche WR: Mast cells and tumour angiogenesis: the tumor-mediated release of an endothelial growth factor from mast cells. Int J Cancer 36: 721-728, 1985.
25. della Rovere F, Granata A, Pavia R, Tomaino A, Zirilli A, Monaco F, Familiari D, La Rocca A, Ientile R, Mondello B, Basile G and Monaco M: Vitamins A, E, microelements and membrane lipid peroxidation in patients with neoplastic disease treated with calcium antagonists and antagonists of receptors H2. Anticancer Res 24: 1449-1453, 2004.
26. Naik R, Baliga P, Bansal R and Pai M: Distribution of mast cells in the axillary lymph nodes of breast cancer patients. J Indian Med Assoc 95: 606-607, 1997.
27. Vakkala M, Paakko P and Soini Y: eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int J Oncol 17: 667-671, 2000.
28. Martin JH, Begum S, Alalami O, Harrison A and Scott KW: Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 21: 90-97, 2000.
29. Gilchrist M, Hesslinger C and Befus AD: Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells. J Biol Chem 278: 50607-50614, 2003.
30. Gilchrist M, McCauley SD and Befus AD: Expression, localization and regulation of nitric oxide synthase (NOS) in human mast cell lines: Effects on leukotriene production. Blood 104: 462-469, 2004.
31. Della Rovere F, Granata A, Familiari D, Zirilli A, Cimino F, and Tomaino A: Histamine and selenium in lung cancer. Anticancer Res 26: 2937-2942, 2006.